Vineet Laboratories Limited (BOM:543298)
India · Delayed Price · Currency is INR 39.27
+3.00 (8.27%)
At close: Apr 21, 2026
Vineet Laboratories Revenue
Vineet Laboratories had revenue of 156.96M INR in the quarter ending December 31, 2025, a decrease of -13.43%. This brings the company's revenue in the last twelve months to 560.13M, down -43.36% year-over-year. In the fiscal year ending March 31, 2025, Vineet Laboratories had annual revenue of 769.53M, down -49.03%.
Revenue (ttm)
560.13M
Revenue Growth
-43.36%
P/S Ratio
1.34
Revenue / Employee
9.83M
Employees
57
Market Cap
753.08M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 769.53M | -740.11M | -49.03% |
| Mar 31, 2024 | 1.51B | -613.29M | -28.89% |
| Mar 31, 2023 | 2.12B | 211.21M | 11.05% |
| Mar 31, 2022 | 1.91B | -523.07M | -21.48% |
| Mar 31, 2021 | 2.43B | - | - |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Kimia Biosciences | 1.26B |
| Smruthi Organics | 1.11B |
| Panchsheel Organics | 1.03B |
| Resonance Specialties | 899.72M |
| Tyche Industries | 505.54M |
| Vasundhara Rasayans | 315.86M |
| Auro Laboratories | 284.46M |
| Krebs Biochemicals & Industries | 230.23M |